Regulus Therapeutics
RGLS
#9133
Rank
โ‚ฌ83.24 M
Marketcap
1,27ย โ‚ฌ
Share price
-6.76%
Change (1 day)
-41.15%
Change (1 year)

Regulus Therapeutics (RGLS) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ0.43 Million

According to Regulus Therapeutics's latest financial reports the company's total debt is โ‚ฌ0.43 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Regulus Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ2.16 M-63.08%
2022-12-31โ‚ฌ5.85 M-6.5%
2021-12-31โ‚ฌ6.26 M65.53%
2020-12-31โ‚ฌ3.78 M-71.04%
2019-12-31โ‚ฌ13.06 M-9.86%
2018-12-31โ‚ฌ14.48 M-12.46%
2017-12-31โ‚ฌ16.55 M-12.08%
2016-12-31โ‚ฌ18.82 M
2014-12-31โ‚ฌ19.23 M135.55%
2013-12-31โ‚ฌ8.16 M6.61%
2012-12-31โ‚ฌ7.66 M-0.51%
2011-12-31โ‚ฌ7.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ19.63 B 4,478,030.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ17.16 B 3,914,458.82%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ6.10 B 1,392,820.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ27.73 B 6,326,370.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ1.19 B 272,179.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ25.53 M 5,725.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.15 B 10,756,202.52%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA